Perioperative

NAPA Expands Anesthesia Services to University of Maryland Capital Region Health

Retrieved on: 
Monday, July 6, 2020

MELVILLE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Effective July 6, 2020, North American Partners in Anesthesia (NAPA) will provide anesthesia services for two facilities affiliated with University of Maryland Capital Region Health (UM Capital): UM Prince Georges Hospital Center and UM Laurel Medical Center.

Key Points: 
  • MELVILLE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Effective July 6, 2020, North American Partners in Anesthesia (NAPA) will provide anesthesia services for two facilities affiliated with University of Maryland Capital Region Health (UM Capital): UM Prince Georges Hospital Center and UM Laurel Medical Center.
  • NAPA is one of the leading single-specialty anesthesia and perioperative management companies in the U.S. UM Capital is among the top healthcare providers in the state of Maryland.
  • We believe NAPA will be an excellent partner to University of Maryland Capital Region Health as we move forward to an even brighter future.
  • NAPA is pleased to partner with University of Maryland Capital Region Health and welcome this new team of anesthesia clinicians who will be joining our organization, said Scott J. Wiesenberger, MD, NAPA Area Vice President, Maryland.

Gynesonics Announces Publication of CHOICES: A Comparative Study of the Sonata Treatment VERSUS Myomectomy

Retrieved on: 
Tuesday, June 30, 2020

The study compared the short-term resource utilization, facility costs, and perioperative patient outcomes for transcervical fibroid ablation (TFA) using the Sonata system compared to myomectomy.

Key Points: 
  • The study compared the short-term resource utilization, facility costs, and perioperative patient outcomes for transcervical fibroid ablation (TFA) using the Sonata system compared to myomectomy.
  • All procedure, anesthesia, laboratory, pathology, and pharmacy costs were significantly higher for myomectomy as compared to TFA with Sonata.
  • TFA was also associated with significantly lower facility procedure-related costs compared to myomectomy, including inpatient, abdominal, or laparoscopic myomectomy.
  • CHOICES, an essential head-to-head comparator study, now demonstrates the procedural cost and early patient outcome advantages provided by Sonata over myomectomy.

Picis Announces Release of Orchestrator, Surgical Staff Scheduling Module

Retrieved on: 
Monday, May 18, 2020

WAKEFIELD, Mass., May 18, 2020 /PRNewswire-PRWeb/ -- Picis Clinical Solutions, Inc. (Picis) , a global provider of clinical information solutions announces the release of Orchestrator.

Key Points: 
  • WAKEFIELD, Mass., May 18, 2020 /PRNewswire-PRWeb/ -- Picis Clinical Solutions, Inc. (Picis) , a global provider of clinical information solutions announces the release of Orchestrator.
  • As hospitals around the globe begin the process of addressing enormous surgical backlogs as a result of the current global pandemic, Orchestrator's Scheduling Module is designed to reduce the time it takes to create and maintain surgical schedules.
  • With Orchestrator , facilities can automate their ability to optimize staff skillsets, surgeon preferences, and asset availability, to provide comprehensive scheduling to help eliminate wasted OR time.
  • Picis Clinical Solutions (Picis) is a global provider of clinical information solutions that automate the entire perioperative experience with one contiguous patient record, from preop to intraop and anesthesia through PACU.

West Cancer Center & Research Institute Names New Chief Financial Officer, Matt Johnson

Retrieved on: 
Tuesday, May 5, 2020

GERMANTOWN, Tenn., May 5, 2020 /PRNewswire/ --West Cancer Center & Research Institute announcedtoday, seasoned financial professional, Matt Johnson,is joining the leading regional cancer center as its new Chief Financial Officer (CFO), effectiveMay 3, 2020.

Key Points: 
  • GERMANTOWN, Tenn., May 5, 2020 /PRNewswire/ --West Cancer Center & Research Institute announcedtoday, seasoned financial professional, Matt Johnson,is joining the leading regional cancer center as its new Chief Financial Officer (CFO), effectiveMay 3, 2020.
  • Johnson joinsWestfrom Medical Anesthesia Group, the largest independent Anesthesia and Perioperative Services Provider in the Southeast, where he served as the Practice Administrator and Chief Operating Officer.
  • Johnson brings with him an extensive background in corporate finance, financial planning and analysis, strategic planning and risk management along with a deep appreciation forhealthcare, especially oncology care and research.
  • Matt and his financial team recognize and appreciate the unique opportunity they have to serve patients in a very tangible way.

North American Partners in Anesthesia (NAPA) Expands its Partnership with OSF HealthCare, Welcomes Anesthesia Clinicians at OSF Saint Anthony Medical Center

Retrieved on: 
Thursday, April 30, 2020

MELVILLE, N.Y., April 30, 2020 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, announces that it is expanding anesthesia services in Illinois with the addition of OSF Saint Anthony Medical Center (OSF Saint Anthony) in Rockford, Illinois.

Key Points: 
  • MELVILLE, N.Y., April 30, 2020 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, announces that it is expanding anesthesia services in Illinois with the addition of OSF Saint Anthony Medical Center (OSF Saint Anthony) in Rockford, Illinois.
  • NAPA is delighted to welcome the anesthesia clinicians at OSF Saint Anthony, who will be invited to continue to provide clinical care to OSF Saint Anthony patients as new members of the NAPA team beginning October 1, 2020.
  • Paula Carynski, President of OSF Saint Anthony, said, We believe NAPA will be an excellent anesthesia partner for us.
  • As a clinician-led organization, North American Partners in Anesthesia is redefining healthcare, delivering unsurpassed excellence to its partners and patients every day.

The Patient Safety Movement Foundation and Anesthesia Patient Safety Foundation Award the Patient Safety Curriculum Award

Retrieved on: 
Monday, March 23, 2020

The Anesthesia Patient Safety Foundation (APSF) and the Patient Safety Movement Foundation (PSMF) are proud to announce that Brian Bensadigh, MD, MBA of the Keck School of Medicine of USC, has been awarded the 2020 Patient Safety Curriculum Award (PSCA).

Key Points: 
  • The Anesthesia Patient Safety Foundation (APSF) and the Patient Safety Movement Foundation (PSMF) are proud to announce that Brian Bensadigh, MD, MBA of the Keck School of Medicine of USC, has been awarded the 2020 Patient Safety Curriculum Award (PSCA).
  • Dr. Bensadighs proposal, Perioperative Patient Safety Curriculum for Anesthesia Trainees, was selected from an outstanding field of applications.
  • View the full release here: https://www.businesswire.com/news/home/20200323005073/en/
    Brian Bensadigh, MD, MBA of the Keck School of Medicine of USC the winner of the 2020 Patient Safety Curriculum Award (PSCA) (Photo: Business Wire)
    The 2020 PSCA awards $100,000 to an anesthesia education investigator for the purpose of modifying the PSMFs Actionable Patient Safety Solutions (APSS) #17: Patient Safety Curriculum to specifically address perioperative patient safety.
  • Founded in 1985, the Anesthesia Patient Safety Foundation (APSF) promotes research of perioperative patient safety issues, supports the development of careers in patient safety, provides patient safety educational materials and communications to all anesthesia providers, and advocates for changes in clinical practices that improve patient safety.

AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Spine Surgery

Retrieved on: 
Friday, March 6, 2020

The study plans to examine the perioperative use of DSUVIA in the analgesic regimen for spine surgery.

Key Points: 
  • The study plans to examine the perioperative use of DSUVIA in the analgesic regimen for spine surgery.
  • Perioperative use of DSUVIA in a prospective cohort of patients undergoing spine surgery will be compared to historical controls.
  • DSUVIA was designed to provide rapid analgesia via a non-invasive route and to eliminate dosing errors associated with intravenous (IV) administration.
  • This press release contains forward-looking statements, including, but not limited to, statements related to expected commencement of an investigator-initiated study and the scope of the study.

Drumlin Security Ltd announces ground-breaking document security solutions for Medical charity and Aerospace training business

Retrieved on: 
Wednesday, January 29, 2020

The solutions in both cases meet the additional requirements of scalability and ease of implementation for the content owners.

Key Points: 
  • The solutions in both cases meet the additional requirements of scalability and ease of implementation for the content owners.
  • The first case study is in the medical field - specifically Medical Standards (Standards for Perioperative Nursing).
  • To deliver the solution the source PDF file was converted by Drumlin Security to their special encrypted HTML5 format whilst retaining its look and feel using Drumlin's web-based document viewer.
  • Both these case studies are based on services provided by UK-based PDF Security specialists, Drumlin Security Ltd ( https://www.drumlinsecurity.com/ ).

Agios Presents New Pharmacodynamic and Response Data from Both Cohorts of the Perioperative Study of Vorasidenib and TIBSOVO® (ivosidenib) in Patients with IDH1 Mutant Positive Low-Grade Glioma

Retrieved on: 
Friday, November 22, 2019

Vorasidenib and TIBSOVO are being evaluated as a single agent in an ongoing perioperative study in IDH1 mutant Grade 2/3 glioma.

Key Points: 
  • Vorasidenib and TIBSOVO are being evaluated as a single agent in an ongoing perioperative study in IDH1 mutant Grade 2/3 glioma.
  • As of the July 26, 2019 data cutoff, 49 patients were randomized before surgery, and 39 remain on treatment.
  • The median (range) postoperative treatment duration for all doses was 5.42 (0.913.5) months for vorasidenib and 6.93 (1.013.2) months for TIBSOVO.
  • Grade 3 or higher events occurred in six (25.0%) vorasidenib patients and four (16.0%) TIBSOVO patients, with the majority related to postoperative complications.

Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain

Retrieved on: 
Monday, November 4, 2019

The study objectives were to evaluate the effect of OMIDRIA compared to epinephrine on perioperative fentanyl use and pain in patients undergoing cataract surgery.

Key Points: 
  • The study objectives were to evaluate the effect of OMIDRIA compared to epinephrine on perioperative fentanyl use and pain in patients undergoing cataract surgery.
  • Sixty patients were prospectively assigned to have either OMIDRIA (41 patients) or epinephrine (19 patients) added to the irrigation solution used during surgery.
  • Our study found that OMIDRIA cut intraoperative pain scores in half while markedly reducing the need for fentanyl during cataract surgery, said Dr. Donnenfeld.
  • With the publication of the Donnenfeld opioid-sparing data, Omeros believes that OMIDRIA meets all of CMS requirements for the non-opioid exclusion.